Rapid Whole-Genome Sequencing in Acutely Ill Children: A Single Pediatric Center Experience

Abstract

The aim of this study was to describe the turnaround time, diagnostic yield, and clinical impact of rapid whole-genomic sequencing (rWGS). We conducted a prospective observational study in acutely ill children (0–21 years) with an undiagnosed, potentially genetic abnormality in a children's hospital. A phenotype-prioritized analysis approach for rWGS was utilized. The turnaround times, diagnostic yield, number of genes detected, inheritance pattern, zygosity, and the clinical impact of positive or negative tests were analyzed. Out of a total of 109 children, 92 abnormal (pathogenic or likely pathogenic) gene variants were detected in 60 (55%) patients. There were 45 neonates, 35 infants, and 29 children. The admission location was 49.5, 34.9, and 15.6% in the pediatric intensive care unit (PICU), neonatal intensive care unit (NICU), and cardiac intensive care unit (CICU), respectively. The median (interquartile range [IQR]) times for the return of preliminary and final results were 3 (2–5) and 10 (6–14) days, respectively. With ultra-rapid processing, the median time to final results was shorter (5 [3–7] vs. 12 [7.75–15] days). Neurologic issues were the most common underlying admission diagnoses. The diagnostic yield for a causative gene was 47.7%. The diagnostic yield was not different based on age group or location of admission but higher in metabolic issues (78.6 vs. 43.2%; odds ratio [OR]: 4.8; 95% confidence interval [CI]: 1.3–18.4). There was a change in clinical management in 39.4%. In acutely ill children with undiagnosed conditions and with clinical suspicion of a genetic disorder, rWGS detected gene variants in 55% with a diagnostic yield of 47.7% and resulted in a change in the management in 39.4%. The diagnostic yield in patients with metabolic conditions was the highest.

Keywords

whole-genome sequencing - whole-exome sequencing - genetic disorder - critical illness - child - phenotype

Role of Funders

The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding organizations. The funding organizations had no role in the design, preparation, review, or approval of this study.

Note

Location: The study was conducted at Nicklaus Children''s Hospital, 3100 SW 62nd Ave, Miami, FL 33155, United States.

Publication History

Received: 26 March 2024

Accepted: 07 August 2024

Article published online:
11 September 2024

• References

• 1 Wojcik MH, Stadelmaier R, Heinke D, Holm IA, Tan WH, Agrawal PB. The unrecognized mortality burden of genetic disorders in infancy. Am J Public Health 2021; 111 (S2): S156-S162
• 2 Xu J, Murphy SL, Kockanek KD, Arias E. Mortality in the United States, 2018. NCHS Data Brief 2020; 355: 1-8
• 3 OMIM. OMIM Morbid Map Scorecard. Johns Hopkins University. Updated May 6, 2022. Accessed May 7, 2022 at: https://www.omim.org/statistics/geneMap
• 4 Kingsmore SF, Cakici JA, Clark MM. et al; RCIGM Investigators. A randomized, controlled trial of the analytic and diagnostic performance of singleton and trio, rapid genome and exome sequencing in ill infants. Am J Hum Genet 2019; 105 (04) 719-733
• 5 Franck LS, Dimmock D, Hobbs C, Kingsmore SF. Rapid whole-genome sequencing in critically Ill children: shifting from unease to evidence, education, and equitable implementation. J Pediatr 2021; 238: 343
• 6 Sweeney NM, Nahas SA, Chowdhury S. et al. Rapid whole genome sequencing impacts care and resource utilization in infants with congenital heart disease. NPJ Genom Med 2021; 6 (01) 29
• 7 Dimmock DP, Clark MM, Gaughran M. et al; RCIGM Investigators. An RCT of rapid genomic sequencing among seriously ill infants results in high clinical utility, changes in management, and low perceived harm. Am J Hum Genet 2020; 107 (05) 942-952
• 8 Bamborschke D, Özdemir Ö, Kreutzer M. et al. Ultra-rapid emergency genomic diagnosis of Donahue syndrome in a preterm infant within 17 hours. Am J Med Genet A 2021; 185 (01) 90-96
• 9 Sanford E, Wong T, Ellsworth KA, Ingulli E, Kingsmore SF. Clinical utility of ultra-rapid whole-genome sequencing in an infant with atypical presentation of WT1-associated nephrotic syndrome type 4. Cold Spring Harb Mol Case Stud 2020; 6 (04) a005470
• 10 Kernan KF, Ghaloul-Gonzalez L, Vockley J, Carcillo JA. Rapid whole genome sequencing and fulfilling the promise of precision pediatric critical care. Pediatr Crit Care Med 2019; 20 (11) 1085-1086
• 11 Sanford EF, Clark MM, Farnaes L. et al; RCIGM Investigators. Rapid whole genome sequencing has clinical utility in children in the PICU. Pediatr Crit Care Med 2019; 20 (11) 1007-1020
• 12 Clark MM, Hildreth A, Batalov S. et al. Diagnosis of genetic diseases in seriously ill children by rapid whole-genome sequencing and automated phenotyping and interpretation. Sci Transl Med 2019; 11 (489) eaat6177
• 13 Briggs B, James KN, Chowdhury S. et al; RCIGM Investigators. Novel Factor XIII variant identified through whole-genome sequencing in a child with intracranial hemorrhage. Cold Spring Harb Mol Case Stud 2018; 4 (06) a003525
• 14 Chen DY, Chowdhury S, Farnaes L. et al. Rapid diagnosis of KCNQ2-associated early infantile epileptic encephalopathy improved outcome. Pediatr Neurol 2018; 86: 69-70
• 15 Farnaes L, Hildreth A, Sweeney NM. et al. Rapid whole-genome sequencing decreases infant morbidity and cost of hospitalization. NPJ Genom Med 2018; 3: 10
• 16 Farnaes L, Nahas SA, Chowdhury S. et al; RCIGM Investigators. Rapid whole-genome sequencing identifies a novel GABRA1 variant associated with West syndrome. Cold Spring Harb Mol Case Stud 2017; 3 (05) a001776
• 17 Hildreth A, Wigby K, Chowdhury S. et al; RCIGM Investigators. Rapid whole-genome sequencing identifies a novel homozygous NPC1 variant associated with Niemann-Pick type C1 disease in a 7-week-old male with cholestasis. Cold Spring Harb Mol Case Stud 2017; 3 (05) a001966
• 18 Petrikin JE, Willig LK, Smith LD, Kingsmore SF. Rapid whole genome sequencing and precision neonatology. Semin Perinatol 2015; 39 (08) 623-631
• 19 Willig LK, Petrikin JE, Smith LD. et al. Whole-genome sequencing for identification of Mendelian disorders in critically ill infants: a retrospective analysis of diagnostic and clinical findings. Lancet Respir Med 2015; 3 (05) 377-387
• 20 Priest JR, Ceresnak SR, Dewey FE. et al. Molecular diagnosis of long QT syndrome at 10 days of life by rapid whole genome sequencing. Heart Rhythm 2014; 11 (10) 1707-1713
• 21 Saunders CJ, Miller NA, Soden SE. et al. Rapid whole-genome sequencing for genetic disease diagnosis in neonatal intensive care units. Sci Transl Med 2012; 4 (154) 154ra135
• 22 Febres-Aldana CA, Pelaez L, Wright MS. et al. A case of UDP-galactose 4′-epimerase deficiency associated with dyshematopoiesis and atrioventricular valve malformations: an exceptional clinical phenotype explained by altered n-glycosylation with relative preservation of the Leloir pathway. Mol Syndromol 2020; 11 (5–6): 320-329
• 23 Karolak JA, Bacolla A, Liu Q. et al. A recurrent 8 bp frameshifting indel in FOXF1 defines a novel mutation hotspot associated with alveolar capillary dysplasia with misalignment of pulmonary veins. Am J Med Genet A 2019; 179 (11) 2272-2276
• 24 Richards S, Aziz N, Bale S. et al; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17 (05) 405-424
• 25 Kearney HM, Thorland EC, Brown KK, Quintero-Rivera F, South ST. Working Group of the American College of Medical Genetics Laboratory Quality Assurance Committee. American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants. Genet Med 2011; 13 (07) 680-685
• 26 South ST, Lee C, Lamb AN, Higgins AW, Kearney HM. Working Group for the American College of Medical Genetics and Genomics Laboratory Quality Assurance Committee. ACMG Standards and Guidelines for constitutional cytogenomic microarray analysis, including postnatal and prenatal applications: revision 2013. Genet Med 2013; 15 (11) 901-909
• 27 Petrikin JE, Cakici JA, Clark MM. et al. The NSIGHT1-randomized controlled trial: rapid whole-genome sequencing for accelerated etiologic diagnosis in critically ill infants. NPJ Genom Med 2018; 3 (01) 6
• 28 French CE, Delon I, Dolling H. et al; NIHR BioResource—Rare Disease, Next Generation Children Project. Whole genome sequencing reveals that genetic conditions are frequent in intensively ill children. Intensive Care Med 2019; 45 (05) 627-636
• 29 Mestek-Boukhibar L, Clement E, Jones WD. et al. Rapid Paediatric Sequencing (RaPS): comprehensive real-life workflow for rapid diagnosis of critically ill children. J Med Genet 2018; 55 (11) 721-728
• 30 Álvarez-Mora MI, Sánchez A, Rodríguez-Revenga L. et al. Diagnostic yield of next-generation sequencing in 87 families with neurodevelopmental disorders. Orphanet J Rare Dis 2022; 17 (01) 60
• 31 Stark Z, Lunke S, Brett GR. et al; Melbourne Genomics Health Alliance. Meeting the challenges of implementing rapid genomic testing in acute pediatric care. Genet Med 2018; 20 (12) 1554-1563
• 32 de Castro MJ, González-Vioque E, Barbosa-Gouveia S. et al. Rapid phenotype-driven gene sequencing with the neoseq panel: a diagnostic tool for critically ill newborns with suspected genetic disease. J Clin Med 2020; 9 (08) 2362
• 33 Tan TY, Lunke S, Chong B. et al. A head-to-head evaluation of the diagnostic efficacy and costs of trio versus singleton exome sequencing analysis. Eur J Hum Genet 2019; 27 (12) 1791-1799
• 34 Clark MM, Stark Z, Farnaes L. et al. Meta-analysis of the diagnostic and clinical utility of genome and exome sequencing and chromosomal microarray in children with suspected genetic diseases. NPJ Genom Med 2018; 3 (01) 16
• 35 Carneiro TN, Krepischi AC, Costa SS. et al. Utility of trio-based exome sequencing in the elucidation of the genetic basis of isolated syndromic intellectual disability: illustrative cases. Appl Clin Genet 2018; 11: 93-98
• 36 Mandelker D, Schmidt RJ, Ankala A. et al. Navigating highly homologous genes in a molecular diagnostic setting: a resource for clinical next-generation sequencing. Genet Med 2016; 18 (12) 1282-1289
• 37 Bellomo R, Warrillow SJ, Reade MC. Why we should be wary of single-center trials. Crit Care Med 2009; 37 (12) 3114-3119